S. Korea's DB Pharm Korea Licenses Ibuprofen From Cumberland Of U.S.
This article was originally published in PharmAsia News
Executive Summary
South Korean pharma DB Pharm Korea has signed a deal with U.S.-based Cumberland Pharmaceuticals to license its Caldolor (ibuprofen) injectable painkiller